| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |